Editors-in-Chief

Dr. Mark J. Ratain, MD
Editor-in-Chief,
Professor, Department of Medicine
University of Chicago, USA
Expertise: Clinical pharmacology, oncology drug development

Dr. Annette C. Dolphin, PhD
Editor-in-Chief,
Professor, Department of Neuroscience, Physiology, and Pharmacology
University College London, UK
Expertise: Ion channels, pharmacology of pain management

Dr. Thomas P. Davis, PhD
Editor-in-Chief,
Professor, Department of Pharmaceutical Sciences
University of Colorado, USA
Expertise: Blood-brain barrier pharmacology, neuroinflammation

Associate Editors

Dr. Hans-Georg Eichler, MD, MSc
Senior Medical Officer
European Medicines Agency, Netherlands
Expertise: Regulatory science, drug safety, clinical trial design

Dr. Philip D. Hansten, PharmD
Professor Emeritus, Department of Pharmacy
University of Washington, USA
Expertise: Drug interactions, clinical pharmacokinetics

Dr. Susan Band Horwitz, PhD
Distinguished Professor, Department of Molecular Pharmacology
Albert Einstein College of Medicine, USA
Expertise: Cancer drug discovery, microtubule inhibitors

Dr. Barry P. Sleigh, PhD
Professor, Department of Medicinal Chemistry
University of Cambridge, UK
Expertise: Computational drug design, structure-based drug discovery

Dr. Daniel J. Drucker, MD
Professor, Department of Medicine
University of Toronto, Canada
Expertise: Diabetes therapeutics, GLP-1 receptor agonists

Dr. Simon Campbell, PhD
Professor, Department of Chemistry
University of Oxford, UK
Expertise: Drug synthesis, medicinal chemistry

Dr. Raymond L. Woosley, MD, PhD
Professor Emeritus, Department of Pharmacology
University of Arizona, USA
Expertise: Drug safety, cardiovascular pharmacology

Editorial Board Members

Dr. Christopher T. Walsh, PhD
Professor, Department of Biological Chemistry and Molecular Pharmacology
Harvard Medical School, USA
Expertise: Antibiotic drug development, enzymology

Dr. Peter Goadsby, MD, PhD
Professor, Department of Neurology
King’s College London, UK
Expertise: Migraine treatment, neuropharmacology

Dr. Claire Steves, MD, PhD
Professor, Department of Aging and Pharmacology
King’s College London, UK
Expertise: Drug metabolism in elderly patients, geriatric medicine

Dr. Andreas Pfefferkorn, PhD
Professor, Department of Drug Discovery and Development
Novartis Institutes for BioMedical Research, Switzerland
Expertise: Small molecule drug development, protein-targeted therapies

Dr. Jeffrey Karp, PhD
Professor, Department of Medicine
Brigham and Women’s Hospital, Harvard Medical School, USA
Expertise: Biomaterials for drug delivery, regenerative medicine

Dr. Silvia Giordani, PhD
Professor, Department of Chemistry and Pharmaceutical Sciences
Dublin City University, Ireland
Expertise: Nanomedicine, targeted drug delivery

Dr. Jean-Pierre Changeux, PhD
Professor, Department of Neuroscience
Collège de France, France
Expertise: Neurotransmitter pharmacology, receptor biology

Dr. Ulrich Holzgrabe, PhD
Professor, Department of Pharmaceutical and Medicinal Chemistry
University of Würzburg, Germany
Expertise: Analytical pharmacology, drug stability

Dr. Pierre Sonveaux, PhD
Professor, Department of Molecular Pharmacology
Université catholique de Louvain, Belgium
Expertise: Cancer metabolism, hypoxia-targeted drugs

Dr. Aideen Sullivan, PhD
Professor, Department of Anatomy and Neuroscience
University College Cork, Ireland
Expertise: Parkinson’s disease treatment, neuroprotective drug development

Dr. Vassilis Gorgoulis, MD, PhD
Professor, Department of Histology and Embryology
University of Athens, Greece
Expertise: Cancer therapy resistance, molecular oncology

Dr. Angela Russell, PhD
Professor, Department of Chemistry
University of Oxford, UK
Expertise: Drug repurposing, synthetic organic chemistry

Dr. Matthias G. Wacker, PhD
Professor, Department of Pharmaceutical Technology
National University of Singapore, Singapore
Expertise: Nanopharmaceuticals, drug formulation

Dr. Markus Zeitlinger, MD
Professor, Department of Clinical Pharmacology
Medical University of Vienna, Austria
Expertise: Infectious disease therapeutics, pharmacokinetics

Dr. Gabriele Costantino, PhD
Professor, Department of Drug Design and Medicinal Chemistry
University of Parma, Italy
Expertise: Computational drug discovery, neuroactive compounds

Dr. Francesca Di Lisa, PhD
Professor, Department of Molecular Medicine
University of Padua, Italy
Expertise: Mitochondrial pharmacology, cardiovascular drugs

Dr. Giovanni Della Sala, PhD
Professor, Department of Experimental Pharmacology
University of Milan, Italy
Expertise: Epigenetics in drug development, personalized medicine